Roche’s TNKase — A Groundbreaking Advancement in Acute...

added blog Health

2025-08-18 14:15:43 -

Roche’s TNKase — A Groundbreaking Advancement in Acute Ischemic Stroke Therapy

Roche, a leader in thrombosis and stroke prevention, has achieved a significant milestone with the FDA approval of TNKase (tenecteplase) for acute ischemic stroke (AIS). This marks the first new drug in nearly 30 years to enter the AIS treatment landscape. Developed by Genentech, part of the Roche Group, TNKase (tenecteplase) provides a faster-acting alternative to the traditional alteplase,...

0 Comments 0 Shares 15 Views 0 Reviews